SAEVA Proceedings 2016 | Page 139

  In general, most operators prefer to transfer a day 7 or 8 embryo into a recipient that has ovulated 0-2 days after the donor; this is difficult if donors and recipients are synchronized on a one-to-one basis, and is more easily achieved by having access to a large herd of recipients or beginning with a minimum of 2 recipients per donor. While a number of hormonal regimes have been described for synchronizing the oestrous cycle in the mare (for review see Allen 2005), the author prefers to limit himself to a simple combination of frequent ultrasonographic examination of the ovaries combined with tactical use of a PGF2a analogue and/or hCG. PGF2a analogues can be usefully administered to a mare with a functional corpus luteum (CL) at least 5 days old, where the relative timing of administration to donor and recipient is based on the respective size of their largest ovarian follicle. Once the mares are in oestrus, follicle development should be monitored regularly and synchronization can be fine-tined by using hCG to ensure ovulation of a >35mm follicle within 48 hours; this can be extremely useful in ensuring that a recipient does not ovulate more than one day before the donor (i.e. treat the donor if the recipient shows signs of imminent ovulation), but does ovulate within two days after (i.e. treat the recipient as soon as ovulation is detected in the donor). An alternative approach described for ensuring adequate ‘hormonal synchrony’ of a recipient, is to use an ovariectomised or seasonally anestrous mare treated with progestagens from soon after the donor has ovulated (Hinrichs et al. 1987); this approach may be particularly useful early in the season when relatively few cycling recipients are available. Although the numbers of reported transfers to such acyclic progestagentreated mares are low, pregnancy and pregnancy loss rates do not appear to differ significantly to synchronized cycling mares (Carnevale et al. 2000; Pessoa et al. 2002), as long as an adequate dose of progestagen is administered until there is sufficient endogenous production of progestagens from either eCG-induced secondary corpora lutea or the placenta (McKinnon et al. 1988). Other aspects of ‘recipient suitability’ Although synchrony of ovulation is the most important component of recipient suitability, there are a number of other factors that affect the likelihood of establishing and maintaining pregnancy. Recipients should be in good general health and body condition, and they should be relatively young (3-12 years old) since age is an important predisposing factor to endometrial degeneration likely to compromise the ability to maintain pregnancy (Ricketts and Alonso 1991: Morris et al. 2002); indeed, recipients older than 10 years appear to be at greater risk of losing an ET pregnancy (Carnevale et al. 2000). A recipient should also exhibit normal cyclicity and show no obvious signs of reproductive tract pathology (e.g. endometrial cysts, uterine fluid accumulation, pneumovagina). Of paramount importance for a mare intended as a transcervical ET recipient, is that the cervix is undamaged and not unduly tortuous; failure to negotiate the cervix and enter the uterine lumen or the need to digitally assist the passage of the pipette are probably common reasons for failure 15-­‐18  February  2016      East  London  Convention  Centre,  East  London,  South  Africa     138